Summary

The Japanese respiratory care equipment market is expanding rapidly because of a mix of demographic trends, technical developments, and a strong commitment to strengthening healthcare infrastructure. With an aging population and an increase in respiratory illnesses, Japan's desire for cutting-edge respiratory care products has never been greater. Japan has a distinct healthcare landscape defined by a large population of elderly people. The prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea has increased significantly as the population ages. Furthermore, environmental factors such as air pollution and pollen allergies contribute to the country's respiratory health issues. In order to tackle these concerns, Japan has prioritized improving respiratory care. Japan has one of the world's fastest-aging populations. Elderly people are more vulnerable to respiratory diseases, particularly COPD. The expanding senior population drives up demand for respiratory care products such as ventilators and oxygen concentrators. Pollution in cities and seasonal allergens have an impact on air quality and contribute to respiratory health problems. As a result, there is a greater need for air purifiers and nebulizers, which aid in mitigating the effects of poor air quality and allergies. The Japanese government has taken a proactive approach to treating respiratory health issues. Measures to address air pollution, healthcare changes to enhance access to respiratory care, and subsidies to promote the purchase of breathing devices are among the initiatives. Increased patient education and awareness campaigns have contributed to early diagnosis and treatment of respiratory conditions. As a result, more individuals seek respiratory care devices and services.

According to the research report "Japan Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the Japan Respiratory Care Devices market is expected to add more than USD 300 Million from 2023 to 2028. Japanese producers are among the first to miniaturize respiratory care devices. Portable oxygen concentrators and nebulizers, for example, have become smaller and lighter. This advancement provides patients with increased mobility and convenience, allowing them to continue their respiratory therapy while on the go, thereby increasing their quality of life. Japan has embraced the Internet of Things (IoT) idea and its integration into healthcare. Sensors in smart inhalers track inhaler usage and offer real-time data to both patients and healthcare practitioners. This level of connectedness improves drug adherence, allowing for prompt interventions and changes to treatment strategies. Telehealth and remote monitoring technology have grown in popularity in Japan, particularly in rural areas with limited access to healthcare. Respiratory care devices increasingly have connectivity features that enable healthcare personnel to remotely monitor patients' vital signs, modify settings, and consult with them. This not only increases access to care but also ensures that patients with chronic respiratory diseases are constantly monitored. The development of respiratory care equipment in Japan has been affected by advances in genetic profiling and customized therapy. Healthcare providers can prescribe tailored treatments and therapies, including the selection of the most appropriate breathing devices and drugs, by assessing a patient's genetic makeup. This method results in more effective therapies and better patient outcomes.

Based on type market is bifurcated into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. Therapeutic devices are commonly used respiratory care devices in Japan. Acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and severe asthma exacerbations all require therapeutic devices to be managed. These illnesses frequently necessitate quick and extensive therapy, which therapeutic devices can deliver. Sleep apnea is a prevalent respiratory illness that affects a large number of Japanese people. The primary treatment for obstructive sleep apnea (OSA) is CPAP devices, and their extensive use indicates the necessity of addressing this common problem. In emergency care settings, such as hospitals and ambulances, where patients with acute respiratory distress require immediate intervention, therapeutic devices are critical. Ventilators, for example, are important in giving life-saving care to critically ill patients. Based on disease indication market is divided into Chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other disease indications. Obesity rates in Japan are on the rise. Obesity increases the risk of obstructive sleep apnea (OSA). An older population combined with increased obesity rates has resulted in an increase in sleep apnea diagnoses. In Japan, both healthcare professionals and the general public are becoming more aware of sleep apnea. As a result, more people are seeking diagnosis and treatment for this illness, fueling demand for CPAP machines and related respiratory care technologies. Diagnostic advancements, such as home sleep studies and portable monitoring equipment, have made it easier to identify sleep apnea. As these technologies have improved the efficiency and accuracy of diagnosis, more people are seeking therapy.

Based on end user industry market is divided into hospitals, ambulatory care centers (ACCs), home care settings and other end user. Home care settings is expected to register highest growth rate in Japan respiratory devices market. Family and home life are highly valued in Japanese society. Many patients, particularly the elderly, prefer to get care at home rather than in a hospital. Demand for home-based respiratory care equipment is being driven by this inclination. Technological advancements have enabled the development of compact and user-friendly respiratory care devices suited for home usage. Portable oxygen concentrators and home CPAP devices are easily available, allowing patients to manage their diseases without having to return to the hospital on a regular basis. In Japan, the use of telehealth and remote monitoring has facilitated home-based care. Without leaving their homes, patients can consult with healthcare specialists remotely, receive device guidance, and have their illnesses monitored. Home care settings provide patients with a sense of comfort, familiarity, and independence. Patients can maintain their daily routines, which can positively impact their mental and emotional well-being. Respiratory care devices enable patients to achieve this level of comfort while managing their conditions effectively. Healthcare providers in Japan are actively involved in patient and family education on the use of respiratory care devices in home settings. Proper education enhances patient and caregiver confidence in managing respiratory conditions at home.

Considered in this report:
• Geography: Japan
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Japan Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents